UnitedHealth Group (UNH) Price Target Cut by $30 at Wells Fargo

Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is recognized as one of the 7 Best Non-REIT Dividend Stocks to Invest in [1] - The company operates across various healthcare and services platforms, including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, covering employer plans, Medicare, retirement offerings, and government-sponsored programs [2] - Wells Fargo analyst Stephen Baxter reduced the price target for UnitedHealth Group from $400 to $370 while maintaining an Overweight rating, citing pressure points from disappointing Medicare Advantage rates and concerns regarding Optum Health results [3] Group 2 - The 2026 revenue outlook for UnitedHealth Group fell below Wall Street expectations, primarily due to a proposed 0.09% increase in Medicare Advantage rates for 2027, which was significantly lower than the anticipated 4% to 6% increase [4] - The Centers for Medicare & Medicaid Services' proposal impacted the health insurance sector, causing several stocks to decline as investors adjusted their expectations, with UnitedHealth being particularly sensitive due to its status as the largest Medicare insurer in the U.S. by membership [5]